Real-World Evidence of Collecting Quality of Life (QoL) and Symptoms Perception Using the HM-PRO© Tool As a Patient-Reported Outcome Measure (PROM) in Patients with Lymphoma While Receiving Intravenous Chemotherapy

Autor: Castilla García, Lucía ^*, Ramos Cillán, Sergio ^*, Lopez García, Alberto ^*, Barreras Ruiz, Natalia ^*, Castillo Bazan, Eva ^*, Pascual, Adriana ^*, Riesco Ovelar, Miriam ^*, Urrutia, Celia ^*, Cruz, Susana ^*, Pardo, Alberto ^*, Herrero, Antonio ^*, Perez Saenz, Maria Angeles ^*, Morillo Gilles, Daniel ^*, Llamas Sillero, María Pilar ^*, Becares, Javier ^*, Barriocanal, Carla ^*, Short Apellaniz, Jorge ^*, del Olmo, Marta ^*, Arcos Campillo, Javier ^*, Cordoba, Raul

Publikováno v: In Blood 15 November 2022 140 Supplement 1:5164-5166

Feasibility of Electronic Patient-Reported Outcome (ePRO) Measurement Using PRO-CTCAE® Questionnaire to Improve Quality of Life Assessment and Healthcare Resources Management in Patients with Lymphoma Receiving Intravenous Chemotherapy

Autor: Ramos-Cillan, Sergio ^*, Barreras Ruiz, Natalia ^*, Pascual, Adriana ^*, Castillo Bazan, Eva ^*, Riesco Ovelar, Miriam ^*, Urrutia, Celia ^*, Herrero, Antonio ^*, Cruz, Susana ^*, Pardo, Alberto ^*, Lopez-Garcia, Alberto ^*, Perez-Saenz, Maria Angeles ^*, Murillo, Daniel ^*, Llamas Sillero, María Pilar ^*, Becares, Javier ^*, Barriocanal, Carla ^*, del Olmo, Marta ^*, Short Apellaniz, Jorge ^*, Arcos Campillo, Javier ^*, Cordoba, Raul

Publikováno v: In Blood 15 November 2022 140 Supplement 1:10987-10988

Feasibility of Telemedicine in the Management Strategy of Patients With Lymphoma Amid the COVID-19 Pandemic in Spain: Prospective Observational Study.

Autor: Cordoba R; Department of Hematology, Clinical and Organizational Innovation Unit (UICO), Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Lopez-Garcia A; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Morillo D; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Perez-Saenz MA; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Askari E; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Prieto RE; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Castillo Bazan E; Department of Pharmacy, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Llamas Sillero P; Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Herrero Gonzalez A; Department of Systems and Information Technology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Short Apellaniz J; Clinical and Organizational Innovation Unit (UICO), Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Del Olmo M; Clinical and Organizational Innovation Unit (UICO), Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain., Arcos J; Clinical and Organizational Innovation Unit (UICO), Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.

Publikováno v: JMIR formative research [JMIR Form Res] 2023 Nov 17; Vol. 7, pp. e34128. Date of Electronic Publication: 2023 Nov 17.